Why should you take as little Eltrombopag/Eltrombopag as possible?

Eltrombopag is a drug used to treat chronic immune thrombocytopenia (ITP) and thrombocytopenia caused by bone marrow abnormalities. As a thrombopoietic drug, eltrombopag increases the number of platelets in the blood by promoting their production. However, despite its significant therapeutic effects, patients need to pay special attention to the dosage when using this drug to avoid possible side effects.

First, eltrombopag may be taxing on the liver, especially when used long-term or in overdose. This drug can cause abnormal liver function, so regular monitoring of liver function is required when using it. If too high a dose is used, it may cause elevated liver enzymes, further increasing the risk of liver damage. Therefore, doctors usually adjust the dosage according to the patient's specific conditions and conduct necessary liver function tests during medication.

Second, eltrombopag may also cause an increased risk of thrombosis. Excessive platelet production may increase blood viscosity, thereby increasing the chance of thrombosis. In order to avoid these potential complications, doctors usually rationally adjust drug dosages based on the patient's condition and platelet levels to avoid too high or too low platelet counts.

In addition, Eltrombopag may also have certain effects on the eyes, kidneys and other organs. Overdose may cause retinopathy and even affect vision; it may also affect kidney function, especially in patients with underlying kidney diseases. Therefore, doctors usually keep the dose low and monitor the patient's physiological parameters when using this drug.

In summary, although eltrombopag plays an important role in the treatment of thrombocytopenia, excessive use may bring a series of potential risks, including liver damage, thrombosis, retinopathy, etc. Therefore, patients should strictly follow the doctor's instructions when taking it, avoid adjusting the drug dosage on their own, and regularly monitor physiological indicators to ensure the safety of the drug.

Reference materials:https://go.drugbank.com/drugs/DB06210